Treatment options in renal cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1394, 2003-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment options for esophageal cancer

By Murphy Thomas J Ravi Narayamasamy Reynolds John V

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 18, 2008-12 ,pp. : 3197-3210

Informa Healthcare

Access to resources Recommend Favorite

Treatment options in the management of ovarian cancer

By Kikuchi Yoshihiro Kita Tsunekazu Takano Masashi Kudoh Kazuya Yamamoto Kenji

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 5, 2005-05 ,pp. : 743-754

Informa Healthcare

Access to resources Recommend Favorite

Sorafenib for the treatment of renal cancer

By Strumberg Dirk

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 3, 2012-02 ,pp. : 407-419

Informa Healthcare

Access to resources Recommend Favorite

Pazopanib for the treatment of renal cancer

By Rini Brian Al-Marrawi Mhd Yaser

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 7, 2011-05 ,pp. : 1171-1189

Informa Healthcare

Access to resources Recommend Favorite

Pharmacoeconomics of Available Treatment Options for Metastatic Prostate Cancer

By Zeliadt Steven B. Penson David F.

PharmacoEconomics, Vol. 25, Iss. 4, 2007-01 ,pp. : 309-327

Adis International

Access to resources Recommend Favorite